Skip to Content
Merck
  • Coformer screening using thermal analysis based on binary phase diagrams.

Coformer screening using thermal analysis based on binary phase diagrams.

Pharmaceutical research (2014-02-14)
Hiroyuki Yamashita, Yutaka Hirakura, Masamichi Yuda, Katsuhide Terada
ABSTRACT

The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method. Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies. Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature. The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Adipic acid, 99%
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Supelco
Fumaric acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Citric acid, ≥99.5%, FCC, FG
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Benzoic acid, ACS reagent, ≥99.5%
USP
Sorbic acid, United States Pharmacopeia (USP) Reference Standard
Supelco
2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)
Citric acid, anhydrous, European Pharmacopoeia (EP) Reference Standard
Stearic acid, European Pharmacopoeia (EP) Reference Standard
Fumaric acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Urea, United States Pharmacopeia (USP) Reference Standard
Supelco
Sorbic acid, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Stearic acid, United States Pharmacopeia (USP) Reference Standard
Supelco
Mettler-Toledo Calibration substance ME 51143091, Saccharin, traceable to primary standards (LGC)
Supelco
Benzoic acid, Standard for quantitative NMR, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Urea, European Pharmacopoeia (EP) Reference Standard
USP
Citric acid, United States Pharmacopeia (USP) Reference Standard
Supelco
Urea, analytical standard
Pidolic acid, European Pharmacopoeia (EP) Reference Standard
Adipic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Stearic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
2,5-Dihydroxybenzoic acid, analytical standard
Sigma-Aldrich
Citric acid, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Sigma-Aldrich
Citric acid, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Supelco
Fumaric Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Benzoic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Adipic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland